Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
Sales | 960 | 953 | 203 | 203 | 203 |
Gross Profit | 960 | 953 | 203 | 203 | 203 |
Operating Expenses | 15,139 | 15,154 | 10,085 | 9,764 | 10,606 |
Operating Income | -14,179 | -14,201 | -9,882 | -9,561 | -10,403 |
Other Income | 85 | 117 | 116 | 52 | 12 |
Pre-tax Income | -14,094 | -14,084 | -9,766 | -9,509 | -10,391 |
Net Income Continuous | -14,094 | -14,084 | -9,766 | -9,509 | -10,391 |
Net Income | $-14,094 | $-14,084 | $-9,766 | $-9,509 | $-10,391 |
EPS Basic Total Ops | -5.50 | -5.50 | -3.80 | -3.80 | 7.60 |
EPS Basic Continuous Ops | -5.50 | -5.48 | -3.82 | -3.82 | 1.63 |
EPS Diluted Total Ops | -5.50 | -5.50 | -3.80 | -3.80 | 7.60 |
EPS Diluted Continuous Ops | -5.50 | -5.48 | -3.82 | -3.82 | 1.63 |
EBITDA(a) | $-13,663 | $-13,707 | $-9,477 | $-9,384 | $-10,324 |